Hormonal
Daily supplementation with 300 mg of Palmitoylethanolamide (PEA) combined with 8 weeks of resistance training does not impair skeletal muscle hypertrophy gains compared to placebo.
If you are doing resistance training and need pain relief, 300mg of PEA daily (split into two doses) will not hurt your muscle growth. It is a safe alternative to NSAIDs like ibuprofen, which can sometimes blunt strength gains. Take one capsule before your workout and one before bed.
PEA supplementation, when combined with 8 weeks of strength training, did not impair lean mass gains and it resulted in significantly higher dynamic lower‑body power when compared with the PLA condition.
Why this rating
Double-blind randomized control trial with adequate sample size (n=52) and intention-to-treat analysis.
Source
The Effect of Palmitoylethanolamide (PEA) on Skeletal Muscle Hypertrophy, Strength, and Power in Response to Resistance Training in Healthy Active Adults: A Double-Blind Randomized Control Trial
Zoya Huschtscha et al. · Sports Medicine - Open · 2024
DOI 10.1186/s40798-024-00732-6
More from this paper
- Daily supplementation with 300 mg of Palmitoylethanolamide (PEA) combined with 8 weeks of resistance training significantly improves lower-body dynamic power (jump height) compared to placebo.Good
- Daily supplementation with 300 mg of Palmitoylethanolamide (PEA) combined with 8 weeks of resistance training does not improve upper-body maximal strength (1-RM bench press) compared to placebo.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →